Navigation Links
Sequenom to Present at Two Financial Conferences in March

SAN DIEGO, March 3 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM) today announced that Harry F. Hixson, PhD, chairman and interim CEO, will present an overview of the company at the following conferences in March.

  • ROTH 22nd Annual OC Growth Stock Conference
  • Location: The Ritz Carlton, Dana Point, CA
  • Presentation Date: Wednesday March 17, 2010
  • Presentation time: 9:00am P.T.

  • Barclays Capital 2010 Global Healthcare Conference
  • Location: Loews Miami Hotel, Miami, FL
  • Presentation date: Wednesday, March 24, 2010
  • Presentation time: 2:00pm E.T.

A live webcast and 30-day archive of these presentations will be available at

About Sequenom

Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a Web site at to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom Web site to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the Web site.


SOURCE Sequenom, Inc.

Back to top



SOURCE Sequenom, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sequenom Appoints Two New Board Members
2. SEQUENOM Announces Partnership With GeneWorks for Sales & Marketing of MassARRAY Systems and Applications in Australia
3. SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
4. SEQUENOM Announces Launch of MassARRAY Compact 96 System
5. SEQUENOM to Hold First Quarter 2009 Financial Results Conference Call on April 30
6. Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics
7. Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3
8. Sequenom to Webcast Analyst and Investor Briefing Presentation on September 24
9. Sangamo BioSciences Announces Presentation at Cowen and Company Health Care Conference
10. Tianyin Pharmaceutical Co., Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing on March 9
11. VIVUS to Present at Two Upcoming Investor Conferences
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... This fall, global software solutions ... in five states to develop and pitch their BIG ideas to improve health and ... are competing for votes to win the title of SAP's Teen Innovator, an all-expenses ...
(Date:11/24/2015)... 2015 --> ... released by Transparency Market Research, the global non-invasive prenatal ... of 17.5% during the period between 2014 and 2022. ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ... market to reach a valuation of US$2.38 bn by ...
(Date:11/24/2015)... Nov. 24, 2015  Twist Bioscience, a company ... Leproust, Ph.D., Twist Bioscience chief executive officer, will ... on December 1, 2015 at 3:10 p.m. Eastern ... City. --> --> ... Twist Bioscience is on Twitter. Sign up to ...
(Date:11/24/2015)... ... November 24, 2015 , ... Creation Technologies ... being named to Deloitte's 2015 Technology Fast 500 list of the fastest growing ... a FDA-cleared, Class II medical device that speeds up orthodontic tooth movement by ...
Breaking Biology Technology:
(Date:11/20/2015)... Connecticut , November 20, 2015 ... authentication company focused on the growing mobile commerce market ... CEO, Gino Pereira , was recently interviewed on ... interview will air on this weekend on Bloomberg ... Latin America . --> NXTD ) ("NXT-ID" ...
(Date:11/19/2015)... MOUNTAIN VIEW, Calif. , Nov. 19, 2015 /PRNewswire/ ... authentication market, Frost & Sullivan recognizes BIO-key with the ... Strategy Leadership. Each year, Frost & Sullivan presents this ... comprehensive product line catering to the needs of the ... which the product line meets and expands on customer ...
(Date:11/19/2015)... 2015  Although some 350 companies are actively involved ... few companies, according to Kalorama Information. These include Roche Diagnostics, ... market share of the 6.1 billion-dollar molecular testing market, ... for Molecular Diagnostic s .    ... controlled by one company and only a handful of ...
Breaking Biology News(10 mins):